Global Vaccination Strategy in Future Crisis Response: Communication, Media and Misinformation
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 316
Special Issue Editor
Interests: health communication; risk communication; public health; risk perception; healthcare technology assessment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are excited to announce a Special Issue of the Vaccines journal, entitled "Global Vaccination Strategy in Future Crisis Response: Communication, Media, and Misinformation". We cordially invite you to contribute your valuable research to this important and timely topic.
The ongoing COVID-19 pandemic has highlighted the critical role of effective communication, media, and the management of misinformation in shaping global vaccination strategies during crisis situations. As we anticipate and prepare for future challenges, it becomes crucial to delve deeper into these aspects to improve response and mitigate the impact of misinformation.
This Special Issue aims to gather cutting-edge research and insights from experts across various disciplines. We welcome submissions that explore (but are not limited to) the following themes:
- Vaccination strategies in crisis situations: analysis and evaluation of past, current, and potential future vaccination strategies deployed during global crises.
- Communication strategies for successful vaccination campaigns: understanding the role of communication in promoting vaccine uptake, addressing vaccine hesitancy, and countering misinformation.
- Media influence and impact on vaccination: examining the influence of traditional and social media on public perceptions, vaccine acceptance, and the spread of misinformation.
- Misinformation management and debunking strategies: assessing approaches to effectively identify, debunk, and address vaccine-related misinformation during crises.
- Technology and innovation in vaccination communication: exploring the role of digital platforms, artificial intelligence, and other innovative tools in enhancing vaccination communication strategies.
We encourage original research articles, reviews, perspectives, and case studies that contribute novel insights and practical recommendations. Submissions should align with the aims and scope of the Vaccines journal.
Manuscripts should be submitted online through the Vaccines journal website. Detailed submission guidelines can be found on the journal's website.
We look forward to your valuable contributions to this Special Issue, which promises to shed light on the global vaccination strategy in future crisis response. Your research will play an instrumental role in advancing our understanding and improving public health outcomes worldwide.
Should you have any inquiries or require further information, please do not hesitate to contact us.
Thank you for considering this invitation, and we eagerly anticipate your submissions.
Prof. Dr. Daniel Catalan-Matamoros
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- communication
- misinformation
- media
- journalism
- eHealth
- campaign
- technology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
